試題詳解

10. Which statement is correct?
(A) The PCSK9 protein is a chaperone that binds to HDL receptors on the cell surface.
(B) The PCSK9 protein directs the PCSK9-LDL complex to the ribosome to degrade.
(C) The PCSK9 protein's inhibition results in more HDL receptors on the cell surface.
(D) The current clinically used PCSK9 inhibitors are monoclonal antibodies.
(E) The PCSK9 protein is a vital regulator of circulating HDL receptor levels.